DGS Capital Management LLC Increases Position in Genpact Limited (NYSE:G)

DGS Capital Management LLC boosted its position in Genpact Limited (NYSE:G) by 69.7% in the 3rd quarter, Holdings Channel reports. The fund owned 45,800 shares of the business services provider’s stock after purchasing an additional 18,811 shares during the period. DGS Capital Management LLC’s holdings in Genpact were worth $1,796,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. CWM LLC grew its position in shares of Genpact by 160.8% in the second quarter. CWM LLC now owns 952 shares of the business services provider’s stock valued at $31,000 after purchasing an additional 587 shares during the period. Blue Trust Inc. boosted its holdings in shares of Genpact by 11,038.0% in the 2nd quarter. Blue Trust Inc. now owns 8,799 shares of the business services provider’s stock valued at $290,000 after purchasing an additional 8,720 shares during the last quarter. Riverwater Partners LLC grew its stake in shares of Genpact by 6.0% during the 2nd quarter. Riverwater Partners LLC now owns 10,688 shares of the business services provider’s stock valued at $344,000 after buying an additional 603 shares during the period. Nisa Investment Advisors LLC grew its stake in shares of Genpact by 329.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 10,525 shares of the business services provider’s stock valued at $339,000 after buying an additional 8,075 shares during the period. Finally, Lecap Asset Management Ltd. purchased a new position in shares of Genpact in the 2nd quarter worth $570,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Stock Performance

NYSE G traded down $0.21 during trading hours on Friday, reaching $44.52. The company’s stock had a trading volume of 51,872 shares, compared to its average volume of 1,345,288. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The business has a 50-day simple moving average of $42.28 and a 200 day simple moving average of $37.67. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $47.98. The stock has a market cap of $7.85 billion, a PE ratio of 12.29, a PEG ratio of 1.56 and a beta of 1.18.

Genpact Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a yield of 1.37%. Genpact’s dividend payout ratio is currently 16.76%.

Insider Activity at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Robert W. Baird lifted their price target on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. TD Cowen increased their target price on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research note on Friday, November 8th. Needham & Company LLC boosted their target price on shares of Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, November 11th. Jefferies Financial Group raised their target price on Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 9th. Finally, JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $42.33.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.